July 16, 2025
  • Facebook
  • Twitter
  • LinkedIn

BiomolBiomed Viewpoints

Science in plain words

  • Home
  • News
  • About
    • BiomolBiomed Viewpoints
    • BiomolBiomed Journal
  • Journal Website
  • Reviews
  • pathology
  • microbiology
  • immunology
  • translational medicine
  • genetics
  • biochemistry
  • anatomy
  • molecular biology
  • clinical medicine
  • new methods
  • new medical entities
Latest posts
  • [ July 14, 2025 ] How VHL and HDAC6 Genes Shape Treatment Response in Bladder Cancer Author Summary
  • [ July 11, 2025 ] New Hope Against MRSA: A Promising Antibiotic Combination Author Summary
  • [ July 10, 2025 ] The Reviewer of the Month for July 2025: Zdenko Sonicki, MD, PhD Reviewer of the Month
  • [ July 9, 2025 ] DPP4 Gene Variant Linked to Fatty Liver Risk in Heart Disease Patients Author Summary
  • [ July 7, 2025 ] Pleiotropic Genes Connecting Obesity and Diabetic Microvascular Complications Author Summary
Homenon-small cell lung cancer

non-small cell lung cancer

Thyroid Dysfunction May Predict Better Response to Lung Cancer Immunotherapy
Author Summary

Thyroid Dysfunction May Predict Better Response to Lung Cancer Immunotherapy

June 20, 2025 0

New study links immune-related thyroid issues to improved outcomes in patients with advanced non-small cell lung cancer. Non-Small Cell Lung Cancer: An Ongoing Challenge Non-small cell lung cancer (NSCLC) represents approximately 85% of all lung […]

Chinese researchers discovered novel non-small cell lung cancer therapy targets
Author Summary

Chinese researchers discovered novel non-small cell lung cancer therapy targets

July 7, 2022 0

The most prevalent type of lung cancer is non-small cell lung cancer (NSCLC). The clinical application of targeted medicines has accelerated the advancement of NSCLC treatment. Nevertheless, the prognosis of NSCLC patients is still poor […]

Researchers may have uncovered a new non-small cell lung cancer biomarker
Author Summary

Researchers may have uncovered a new non-small cell lung cancer biomarker

April 25, 2022 0

Non-small cell lung cancer (NSCLC) is the major subtype of lung cancer, and the epidermal growth factor receptor (EGFR) is the major and well-studied gene that can transform a cell into a tumor cell in […]

A novel immune checkpoint for non-small cell lung cancer uncovered
Author Summary

A novel immune checkpoint for non-small cell lung cancer uncovered

February 7, 2022 0

V-domain immunoglobulin suppressor of T-cell activation (VISTA) is a novel negative immune checkpoint that has been linked to immunotherapy resistance and might be used as a therapeutic target. It is found overexpressed in non-small cell […]

The researchers studied the targeted ALK, TKI therapy for lung cancer
Author Summary

The researchers studied the targeted ALK, TKI therapy for lung cancer

August 10, 2021 0

Lung cancer represents one of the top malignancies in cancer-related incidence and mortality worldwide. Throughout the years, efforts have been made to develop new therapeutic options that can provide an improved quality of life and […]

BiomolBiomed journal metrics

  • Impact Factor 2024 (JCR®): 2.2
  • CiteScore 2024 (Scopus): 5.2
  • Google Scholar Citations
  • Dimensions metrics

See more here…

BiomolBiomed Newsletters

Subscribe to receive the latest content and news from Biomolecules and Biomedicine. Choose from our sections or themes of your interest.

Categories

  • Author Summary
  • Conferences
  • Interview
  • News
  • Opinion
  • Reviewer of the Month
  • Topics
  • Video Summary

Archives

TELL US

What matters the most when choosing the journal to submit your article?
Vote
Follow us on Facebook

Copyright (c) 2021 Association of Basic Medical Sciences of FBIH

 

Loading Comments...